Feedback raises £2m to promote clinical messaging tech
Feedback plc in Cambridge, a quoted medical imaging technology company, has conditionally raised £2 million before expenses via a proposed placing and subscription of shares.
Shareholders are being asked to ratify the fund raise at a general meeting on August 29.
The proceeds will be used to complete development of the BleepaTM, Feedback’s clinical messaging product, to build a sales/support team to market and onboard users onto the Bleepa product and for general working capital.
Dr Alastair Riddell, non-executive chairman of Feedback said: “I am delighted with the support shown by new and existing shareholders for our new product BleepaTM.
“This is an evolution from Cadran, devised and driven by the creativity of our CEO Tom Oakley and developed with the assistance of our partners Future Processing.
“We believe BleepaTM is set to transform the outlook for the Company and could change the way medical images are communicated in everyday clinical practice on mobile devices and laptops.”